NCT05346705

Brief Summary

Objectives: To observe the effect of newly-created individualized upper airway muscle functional training on the condition and intraday symptoms of OSA patients; to study the effect of this training method on the excitability of the genioglossus muscle cortex; to analyze the factors affecting the efficacy of upper airway training in the treatment of OSA and screening suitable population for upper airway training: Design: A randomized double-blind controlled trial. SAS 9.3 statistical software (SAS Institute, Cary, North Carolina, USA) was used to generate a random number table, and the selected patients were randomly divided into experimental group 1, experimental group 2, and control group according to the ratio of 1:1:1 with 100 cases each. Unit: Shenyang, China Participants: Consecutive specific OSA patients, who are potential candidates for the treatment of upper airway training (n=300), will be recruited from a sleep center or respirologists, psychiatrists, otolaryngologists and dentists practicing with broad inclusion criteria (age: 20-75 years, AHI:15-50/h; BMI\<40 kg/m2). Interventions: The three groups of subjects completed 7-day functional training and control training of upper airway muscles in different modes, respectively completed polysomnography, neck circumference, Berlin questionnaire and Epworth sleepiness scale before and after training, The genioglossus myoelectric activity was measured after transcranial magnetic stimulation and the excitability of the genioglossus cortex motor center was used to determine the efficacy of different training. After regression analysis, the factors affecting the efficacy of upper airway muscle group training were analyzed to screen the OSA patient population suitable for upper airway muscle group training.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 8, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 26, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

April 26, 2022

Status Verified

April 1, 2022

Enrollment Period

3 years

First QC Date

April 8, 2022

Last Update Submit

April 21, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Sleep Parameters Changes : Apnea Hypopnea Index (AHI)

    Overnight polysomnography with Alice5 (Philips); AHI measured according to American Association of Sleep Medicine (AASM) criteria

    Baseline and 1 Week

  • Sleep Parameters Changes : Oxygen desaturation index (ODI)

    Overnight polysomnography with Alice5 (Philips); ODI measured according to American Association of Sleep Medicine (AASM) criteria

    Baseline and 1 Week

  • Sleep Parameters Changes : Snoring index

    Overnight polysomnography with Alice5 (Philips); Snoring index measured according to American Association of Sleep Medicine (AASM) criteria

    Baseline and 1 Week

Secondary Outcomes (5)

  • Upper Airway Muscle Strength (genioglossus)

    Baseline and 1 Week

  • Upper Airway Muscle Strength (Soft palate muscles)

    Baseline and 1 Week

  • Quality of Life (as measured by Berlin Questionnaire)

    Baseline and 1 Week

  • Cortical motor center excitability of upper airway muscle

    Baseline and 1 Week

  • Daytime sleepiness (as measured by Epworth Sleepiness Scale)

    Baseline and 1 Week

Study Arms (3)

Tongue/soft palate muscle control function training group

EXPERIMENTAL

In the sleep center, patients undergo a week of upper airway muscle training for 2 hours a day under the guidance of a doctor

Behavioral: New individualized upper airway muscle functional training

Soft palate muscle group vocal resistance training group

EXPERIMENTAL

In the sleep center, patients undergo a week of upper airway muscle training for 2 hours a day under the guidance of a doctor

Behavioral: New individualized upper airway muscle functional training

Simple tongue extension, cheek drumming/voice training group

PLACEBO COMPARATOR

In the sleep center, patients undergo a week of upper airway muscle training for 2 hours a day under the guidance of a doctor

Behavioral: New individualized upper airway muscle functional training

Interventions

The two groups of experimental groups were respectively performed tongue/soft palate muscle group control function training and soft palate muscle group vocal resistance training for 7 days.

Simple tongue extension, cheek drumming/voice training groupSoft palate muscle group vocal resistance training groupTongue/soft palate muscle control function training group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recent diagnosis of OSA (AHI\>15 events/h) announced by a sleep recording
  • Mean oxygen saturation \>90%
  • Must be able to complete the training

You may not qualify if:

  • Inability to tolerate overnight polysomnography in sleep lab
  • \>50% of observed sleep apneas being central
  • Other sleep disorders such as insomnia, narcolepsy, chronic sleep deficiency, periodic limb movement disorder or restless legs syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Hospital of China Medical University

Shenyang, Liaoning, 110000, China

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, ObstructiveMuscular Diseases

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMusculoskeletal DiseasesNeuromuscular Diseases

Central Study Contacts

Wenyang Li, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 8, 2022

First Posted

April 26, 2022

Study Start

January 1, 2022

Primary Completion

January 1, 2025

Study Completion

May 1, 2025

Last Updated

April 26, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Data can be requested from researchers after the experiment is over and after the paper is published

Locations